Insider Trading History of Furey Raymond J.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Furey Raymond J. since 2014. This trader's CIK number is 1577899. At the time of last reporting, Furey Raymond J. was the EVP, GC, CCO & Corp Sec of Rigel Pharmaceuticals Inc. (stock ticker symbol RIGL). Also see all insider trading activities at Rigel Pharmaceuticals Inc.

Note that in the past Furey Raymond J. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Rigel Pharmaceuticals Inc (RIGL) by Furey Raymond J.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 RIGL 0 $0 2,787 $59,651 0 $0

Yearly summary of insider trading at Mallinckrodt Plc (MNK) by Furey Raymond J.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2014 MNK 0 $0 31,784 $2,667,789 8,798 $722,802


Insider trading activities at 2 companies by Furey Raymond J.:

1. Rigel Pharmaceuticals Inc (RIGL)

2. Mallinckrodt Plc (MNK)

Table 1. Insider trading of Rigel Pharmaceuticals Inc (RIGL) by Furey Raymond J.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-02-04 RIGL Sale 1,448 20.92 30,293
2025-02-05 RIGL Sale 1,339 21.93 29,358

Table 2. Insider trading of Mallinckrodt Plc (MNK) by Furey Raymond J.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2014-09-02 MNK Sale 1,040 82.34 85,633
2014-09-10 MNK Sale 5,441 85.90 467,381
2014-09-04 MNK Sale 10,012 85.35 854,524
2014-09-05 MNK Sale 4,988 84.09 419,440
2014-08-29 MNK Sale 4,840 80.91 391,589
2014-09-02 MNK Sale 5,463 82.23 449,222
2014-08-29 MNK Option Ex 498 80.91 40,293
2014-09-02 MNK Option Ex 8,300 82.23 682,509

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Furey Raymond J. (EVP, GC, CCO & Corp Sec of Rigel Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.